Related Experiment Video
Updated: Aug 19, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Improving the outcome of tuberculous meningitis in childhood
Insights
Cerebrospinal fluid shunting significantly improves outcomes for children with tuberculous meningitis (TBM) and hydrocephalus. Relieving cerebrospinal fluid flow obstruction is crucial for reducing mortality and morbidity in these patients.
Area of Science:
- Pediatrics
- Neurology
- Infectious Diseases
Background:
- Tuberculous meningitis (TBM) is a severe infection affecting the central nervous system.
- Hydrocephalus is a common complication of TBM, leading to increased intracranial pressure.
- Untreated hydrocephalus in TBM is associated with high mortality and morbidity.
Purpose of the Study:
- To evaluate the efficacy of cerebrospinal fluid (CSF) shunting in managing hydrocephalus secondary to TBM.
- To compare treatment outcomes in TBM patients with hydrocephalus who underwent CSF shunting versus those who did not.
Main Methods:
- A comparative study involving two matched groups of 28 children with TBM and hydrocephalus.
- Both groups received standard antituberculosis therapy.
- One group underwent ventriculoperitoneal or lumboperitoneal CSF shunting procedures.
Main Results:
- Patients who received CSF shunting demonstrated superior treatment outcomes compared to the non-shunted group.
- Shunting effectively relieved the obstruction to CSF flow.
- This intervention was associated with reduced mortality and morbidity.
Conclusions:
- Cerebrospinal fluid shunting is an effective adjunctive treatment for hydrocephalus in children with TBM.
- Relieving CSF flow obstruction through shunting significantly improves patient prognosis.
- Early surgical intervention should be considered for TBM-associated hydrocephalus.
Abstract:
Two groups of 28 children with tuberculous meningitis (TBM) and hydrocephalus were matched for age and stage of the disease and treated with appropriate antituberculosis therapy. The patients in one group were subjected to ventriculoperitoneal or lumboperitoneal cerebrospinal fluid shunting procedures. The results of treatment were assessed in both groups. The outcome in the group of patients subjected to shunting was clearly superior to that in the group in which shunting was not carried out. The hydrocephalus associated with TBM is associated with a significant mortality and morbidity if the obstruction to cerebrospinal fluid flow is not relieved.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
10:24Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells
Published on: May 22, 2026
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Cryptococcal Meningitis